Legal Status of Traditional Medicine and Complementary/alternative Medicine: A Worldwide Review: Produced by the WHO Unit on Traditional Medicine
By Fritz K. BellerVarious types of traditional medicine and other medical practices referred to as complementary or alternative medicine are increasingly used in both developing and developed countries. In order to promote safe and appropriate use of these medicines and practices, as well as to ensure the quality of service and practitioners, national regulations are vital. Establishing national policies on traditional medicine, and/or complementary/alternative medicine and their medical practices, should therefore include creation of legal frameworks. This review summarizes the legal status of several major practices in traditional medicine and complementary/
$13.00$110.00
PayPal & cryptocurrencyGuest checkout available
BETWEEN THE COVERS
About this book
Various types of traditional medicine and other medical practices referred to as complementary or alternative medicine are increasingly used in both developing and developed countries. In order to promote safe and appropriate use of these medicines and practices, as well as to ensure the quality of service and practitioners, national regulations are vital. Establishing national policies on traditional medicine, and/or complementary/alternative medicine and their medical practices, should therefore include creation of legal frameworks. This review summarizes the legal status of several major practices in traditional medicine and complementary/alternative medicine in 123 countries. It includes data on: the use of traditional and complementary/alternative medicines; the regulatory situation of traditional and complementary/alternative remedies and practitioners; health insurance coverage of traditional and complementary/alternative medicine; education and training of practitioners of traditional and complementary/alternative medicine. Information provided in this review should be useful not only to policy makers, but also to researchers, universities, the public, insurance companies and pharmaceutical industries.